« Return to News | Technology Solutions

K&L Consulting Services selects OpenClinica Enterprise clinical trial software

Wednesday, February 13, 2013 09:34 AM

K&L Consulting Services, a CRO based in Fort Washington, Penn., has selected the OpenClinica Enterprise Edition for Electronic Data Capture (ED”) and clinical data management for phase I-IV clinical trials. K&L is increasing the breadth of its capabilities in the U.S. as well as in Asia and the Pacific region, especially in China.

“We welcome this opportunity to work closely with K&L to help them grow their global practice,” said Ben Baumann, COO at OpenClinica, an open source software company based in Waltham, Mass.

OpenClinica’s commercial open source model stands out in the realm of clinical research software. The company’s strategy is to leverage its rapidly growing global community of users and developers (currently nearly 17,000 people) in order to produce high quality software in a more agile and transparent way for use across the spectrum of clinical research.

“OpenClinica Enterprise allows us to deploy studies quickly and cost effectively, and pass this value on to our clients,” said Dr. Henry Wu, vice president of biostatistics and data management, K&L.

The OpenClinica software is available in two editions: The OpenClinica Community Edition is freely available under a common open source license. The OpenClinica Enterprise Edition pairs the open source technology with a regulatory compliance infrastructure and robust support services.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013
Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings
Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving
Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.